Tadashi Takeda

2.6k total citations · 1 hit paper
77 papers, 1.8k citations indexed

About

Tadashi Takeda is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Tadashi Takeda has authored 77 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hepatology, 44 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Tadashi Takeda's work include Liver Disease Diagnosis and Treatment (37 papers), Hepatitis C virus research (26 papers) and Hepatitis B Virus Studies (19 papers). Tadashi Takeda is often cited by papers focused on Liver Disease Diagnosis and Treatment (37 papers), Hepatitis C virus research (26 papers) and Hepatitis B Virus Studies (19 papers). Tadashi Takeda collaborates with scholars based in Japan, United States and Canada. Tadashi Takeda's co-authors include Susumu Shiomi, Shuzo Otani, Shinya Nakajima, S Seki, S. Nishiguchi, Shinji Nakatani, Tomoyuki Kuroki, Kazuhiro Kobayashi, Hideki Morimoto and Shuhei Nishiguchi and has published in prestigious journals such as The Lancet, Hepatology and Biochemical and Biophysical Research Communications.

In The Last Decade

Tadashi Takeda

72 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis

1995 700 citations S. Nishiguchi, Tomoyuki Kuroki et al. The Lancet profile →

Peers

Countries citing papers authored by Tadashi Takeda

Since Specialization

Citations

This map shows the geographic impact of Tadashi Takeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Takeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Takeda more than expected).

Fields of papers citing papers by Tadashi Takeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadashi Takeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Takeda. The network helps show where Tadashi Takeda may publish in the future.

Co-authorship network of co-authors of Tadashi Takeda

This figure shows the co-authorship network connecting the top 25 collaborators of Tadashi Takeda. A scholar is included among the top collaborators of Tadashi Takeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadashi Takeda. Tadashi Takeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Combination Treatment with Leptin and Liraglutide on Glucose Metabolism in Insulin-Dependent Diabetic Mice 2025 ·International Journal of Molecular Sciences ·(unknown), Mariko Sugiyama, (unknown), (unknown), Tadashi Takeda, (unknown), Hiroshi Takagi, Teruhiko Koike, Hiroshi Arima, Ryoichi Banno	0
2	The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas 2015 ·Frontiers in Microbiology ·Michio Suzuki, Tadashi Takeda, (unknown), Seiko Iwata, Takahiro Watanabe, Mohammed Nure Alam Siddiquey, Fumi Goshima, Takayuki Murata, Jun‐ichi Kawada, Yoshinori Ito, Seiji Kojima, Hiroshi Kimura	20
3	Lamivudine and IFN- β Sequential Therapy in HBe Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection 2007 ·Journal of Interferon & Cytokine Research ·Masaru Enomoto, Akihiro Tamori, (unknown), Takehiro Hayashi, Hisato Jomura, Daiki Habu, Hiroki Sakaguchi, Tadashi Takeda, Norifumi Kawada, Shuichi Seki, Susumu Shiomi, Noritoshi Koh, Shuhei Nishiguchi	7
4	Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case–control study 2006 ·Hepatology Research ·Satoko Ohfuji, Wakaba Fukushima, Takashi Tanaka, Daiki Habu, Akihiro Tamori, Hide Sakaguchi, Tadashi Takeda, Norifumi Kawada, S Seki, S. Nishiguchi	45
5	Hepatitis B Virus DNA Integration in Hepatocellular Carcinoma After Interferon-Induced Disappearance of Hepatitis C Virus 2005 ·The American Journal of Gastroenterology ·Akihiro Tamori, Shuhei Nishiguchi, Susumu Shiomi, Takehiro Hayashi, Sawako Kobayashi, Daiki Habu, Tadashi Takeda, Shuichi Seki, Kazuhiro Hirohashi, Hiromu Tanaka, Shoji Kubo	24
6	Association of HLA Alleles with Response (Especially Biochemical Response) to Interferon Therapy in Japanese Patients with Chronic Hepatitis C 2003 ·Journal of Interferon & Cytokine Research ·Shuhei Nishiguchi, (unknown), Motoharu Tanaka, Masaru Enomoto, Akihiro Tamori, Daiki Habu, Tadashi Takeda, (unknown), Takashi Tanaka, Yoshihisa Yano, Susumu Shiomi	5
7	HBV DNA integration and HBV‐transcript expression in non‐B, non‐C hepatocellular carcinoma in Japan 2003 ·Journal of Medical Virology ·Akihiro Tamori, Shuhei Nishiguchi, Shoji Kubo, (unknown), Daiki Habu, Tadashi Takeda, Kazuhiro Hirohashi, Susumu Shiomi	41
8	Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver 2002 ·The American Journal of Gastroenterology ·Susumu Shiomi, Shuhei Nishiguchi, Shoji Kubo, Akihiro Tamori, Daiki Habu, Tadashi Takeda, Hironobu Ochi	28
9	Dynamics of Hepatitis C Virus Monitored by Real-Time Quantitative Polymerase Chain Reaction During First 2 Weeks of IFN- β Treatment Are Predictive of Long-Term Therapeutic Response 2002 ·Journal of Interferon & Cytokine Research ·Masaru Enomoto, Shuhei Nishiguchi, Motoharu Tanaka, Katsuhiko Fukuda, Tadashi Ueda, Akihiro Tamori, Daiki Habu, Tadashi Takeda, Susumu Shiomi, Yoshihisa Yano, Shuzo Otani	6
10	Accurate Prediction of Response to Interferon Therapy by Repeated Measurement of Hepatitis C Virus Core Protein in Patients with Chronic Hepatitis C 2002 ·Intervirology ·Shuhei Nishiguchi, Masaru Enomoto, Motoharu Tanaka, Katsuhiko Fukuda, Akihiro Tamori, Daiki Habu, Tadashi Takeda, Susumu Shiomi, Takashi Tanaka, Yoshihisa Yano, Shuzo Otani	4
11	GB virus C and TT virus infections in Japanese patients with autoimmune hepatitis 2001 ·Journal of Medical Virology ·Shuhei Nishiguchi, Masaru Enomoto, Susumu Shiomi, (unknown), Motoharu Tanaka, Katsuhiko Fukuda, Akihiro Tamori, Daiki Habu, Tadashi Takeda, Takashi Tanaka, Yoshihisa Yano, Shuzo Otani	7
12	TT virus infection in patients with chronic liver disease of unknown etiology 2000 ·Journal of Medical Virology ·Shuhei Nishiguchi, Masaru Enomoto, Susumu Shiomi, Motoharu Tanaka, Katsuhiko Fukuda, Akihiro Tamori, Takashi Tanaka, Tadashi Takeda, Shuichi Seki, Yoshihisa Yano, Shuzo Otani, Tetsuo Kuroki	17
13	Effect of ethanol on bone mineral density of rats evaluated by dual-photon X-ray absorptiometry 2000 ·Journal of Bone and Mineral Metabolism ·Shuhei Nishiguchi, Susumu Shiomi, Akihiro Tamori, Daiki Habu, Tadashi Takeda, Takashi Tanaka, Hironobu Ochi	17
14	Calcitriol for bone loss in patients with primary biliary cirrhosis 1999 ·Journal of Gastroenterology ·Susumu Shiomi, (unknown), Daiki Habu, Tadashi Takeda, Shuhei Nishiguchi, Tetsuo Kuroki, Hironobu Ochi	35
15	Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis breakdown → 1995 ·The Lancet ·S. Nishiguchi, Tomoyuki Kuroki, Shinji Nakatani, Hideki Morimoto, Tadashi Takeda, Shinya Nakajima, Susumu Shiomi, S Seki, Kazuhiro Kobayashi, Shuzo Otani	700
16	Primary biliary cirrhosis complicated by severe hypoxemia 1995 ·Journal of Gastroenterology ·Susumu Shiomi, Tetsuo Kuroki, Shunsuke Fujimoto, (unknown), Hiroki Sakaguchi, Tadashi Takeda, Shuhei Nishiguchi, Shinya Nakajima, Kenzo Kobayashi, Hironobu Ochi	1
17	Therapeutic efficacy of interferon of HCV-RNA in chronic hepatitis C 1991 ·Gastroenterologia Japonica ·Tomoyuki Kuroki, S. Nishiguchi, Tadashi Ueda, (unknown), Keiji Fukuda, Tadashi Takeda, (unknown), Shinya Nakajima, Susumu Shiomi, S Seki, Kazuhiro Kobayashi, Shohei Otani, (unknown), S Yamamoto, Nobuyuki Hayashi, Toshio Shikata	7
18	Effects of Putrescine on D–Galactosamine-Induced Acute Liver Failure in Rats 1990 ·Hepatology ·Shuhei Nishiguchi, Tetsuo Kuroki, Tadashi Takeda, Shinya Nakajima, (unknown), (unknown), Isao Matsui‐Yuasa, Shuzo Otani, Kenzo Kobayashi	39
19	Diffusion bonding of Ti-6Al-4V alloy with an interlayer of Al. 1985 ·QUARTERLY JOURNAL OF THE JAPAN WELDING SOCIETY ·(unknown), Akihiko Yamamoto, Toshihiro Yamada, Tadashi Takeda	2
20	Splenic blood flow in idiopathic portal hypertension in Japan measured by 85Kr clearance method. 1971 ·PubMed ·Haruka Ueda, Kenichi Kitani, (unknown), Tadashi Takeda, Kosuke Chiba, M. Nagatani, Hiroshi Yamada, Iio M	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact